About Dermatology Ottawa Research Centre
Clinical Trials at Dermatology Ottawa Research Centre
During the past decade, Dermatology Ottawa Research Centre conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Dermatology Ottawa Research Centre" #1 sponsor was "Pfizer" with 3 trials, followed by "Incyte Corporation" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Ottawa Research Centre"
#1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Dermatology Ottawa Research Centre
According to Clinical.Site data, the most researched conditions in "Dermatology Ottawa Research Centre" are
"Atopic Dermatitis" (4 trials), "Psoriasis" (3 trials), "Dermatitis, Atopic" (2 trials), "Cutaneous Lupus Erythematosus" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Dermatology Ottawa Research Centre" in a lesser frequency.
Clinical Trials Intervention Types at Dermatology Ottawa Research Centre
Most popular intervention types in "Dermatology Ottawa Research Centre" are "Drug" (9 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Abrocitinib 200 mg" (2 trials), "ABP 654" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dermatology Ottawa Research Centre
The vast majority of trials in "Dermatology Ottawa Research Centre" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Dermatology Ottawa Research Centre
Currently, there are NaN active trials in "Dermatology Ottawa Research Centre".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Dermatology Ottawa Research Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dermatology Ottawa Research Centre, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".